I agree. Given that we are at .30 it seems rather difficult to raise $25m+ for a drug launch. And I have no confidence whatsoever that BLA submission alone will get this up to anywhere near fair value. If CYDY was trading at $1+, hell, yes, they should go alone. But reality is: no money, weekly micro-raises weighing on the SP.

Deal needs to be done to escape that death spiral... Will remove a lot of uncertainties and enable them to focus on cancer, GvHD, mono etc.